Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire

Journal of Sex and Marital Therapy

Volumn 24, Issue 1, 1998, Pages 43-54

  Piletz, John E ^a   Segbaves, Kathleen B ^b   Feng, Yang Zheng ^a   Maguire, Edward ^c   Dunger, Betty ^b   Halaris, Angelos ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Institute for Biological Research and Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ALPHA 2 ADRENERGIC RECEPTOR; PLACEBO; YOHIMBINE;

ARTICLE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LUTEAL PHASE; NORADRENALIN BLOOD LEVEL; OVARY FOLLICLE CELL; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL INTERCOURSE; SEXUALITY;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; FEMALE; HUMANS; MALE; MENSTRUAL CYCLE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; NOREPINEPHRINE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TREATMENT OUTCOME; YOHIMBINE;

EID: 0031985635     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926239808414668     Document Type: Article

References (24)

1. 2adrenoceptor. Pharmacol Rev 35(2): 143-179, 1983.
2. Krystal JH, McDougle CJ, Woods SW, Price LH, Heninger GR, Charney DS: Dose-response relationship for oral idazoxan effects in healthy human subjects: Comparison with oral yohimbine. Psychopharmacol 108: 313-319, 1992.
3. Kopin IJ, Jimerson DC, Markey SP, Ebert MH, Polinsky RJ: Disposition and metabolism of MHPG in humans: Application to studies in depression. Pharmacopsychiatry 27:3-8, 1984.
4. Muller WE, Bauer K, Rost W, Filser JG, Fischer M, Gattaz WF: Urinary MHPG-sulfate and urinary MHPG-glucuronide, two possible markers of the central or peripheral norepinephrine metabolism in man: The effect of alprazolam treatment. Pharmacopsychiatry 21: 371-373, 1988.
5. Pomerleau CS, Garcia AW, Pomerleau OF, Cameron OG: The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: A preliminary report. Psychoneuroendocrinology 17(6): 627-638, 1992.
6. Eriksson E, Ailing C, Andersch B, Andersson K, Berffren U: Cerebrospinal fluid levels of monoamine metabolites. Neuropsychopharmacol 22(3): 201-213, 1994.
7. Holmberg G, Gershon S: Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacol 2:93-106, 1961.
8. Morales A, Surredge DH, Marshall PG, Fenemore J: Nonhormonal pharmacological treatment of organic impotence. J Urol 128: 45-47, 1982.
9. Morales A, Surredge DH, Marshall PG, Fenemore J, Harris C: Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J. Urol 137: 1168-1172, 1987.
10. Riley AJ, Goodman RE, Orr R: Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy. Sex Marital Ther 4(1): 17-28, 1989.
11. Clark JT, Smith ER, Davidson JM: Enhancement of sexual motivation in male rats by yohimbine. Science 225:847-849, 1984.
12. Clark JT, Smith ER, Davidson JM: Evidence for the modulation of sexual behavior by alpha adrenoceptors in male rats. Neuroendocrinology 41: 36-43, 1985.
13. Kucio C, Jonderko K, Piskorska D: Does yohimbine act as a slimming drug? Isr J Med Sa 127: 550-556, 1991.
14. Diagnostic and statistical manual of mental disorders, 3rd ed, rev. Washington, DC: American Psychiatric Association, 1987.
15. Sugita S, Kobayashi A, Suzuki S, Yoshida T, Nakazawa K: Correlative changes of serotonin and catecholamines with pharmacokinetic alterations of imipramine in rat brain. Eur J Pharmacol 165: 191-198, 1989.
16. Derogatis LR, Schmidt CW, Fagan PJ, Wise TN: Subtypes of amorgasmia via mathematical taxonomy. Psychosomatics 30:166-173, 1989.
17. Snyder DK, Regts JM: Personality correlates of married dissatisfaction: A comparison of psychiatric, maritally distressed, and nonclinic samples. J Sex & Marital Therapy 16:34-43, 1990.
18. Piletz JE, Halaris A: Gas-liquid chromatographic method for routine detection of plasma sulfo-, gluco-, and free 3-methoxy-4hydroxyphenylglycol. Clinica CkimicaActa 185:165-176, 1989.
19. Riley AJ: Yohimbine in the treatment of erectile disorder. Br J Clin Pharmacol 48: 133-136, 1994.
20. Reid K, Morales A, Harris C, Surridge DHC, Condra M, Owen J, Fenemore J: Double blind trial of yohimbine in treatment of psychogenic impotence. Lancet: 421-422, August 22, 1987.
21. Parry BL, Gerner RH, Wilkins JN, Halaris AE, Carlson HE, Hershman JM, Linnoila M, Merrill J, Gold PW, Gracely R, Aloi J, Newton R: CSF and endocrine studies of premenstrual syndrome. Neuropsychopharmacol 5(2): 127-137, 1991.
22. Blum I, Nessiel L, David A, Graff E, Harsat A, Weissglas L, Gabbay U, Sulkes J, Yerushalmy Y, Vered Y: Plasma neurotransmitter profile during different phases of the ovulatory cycle.J Clin Endocrinology Metab 75: 924-929, 1992.
23. Heninger GR, Charney DS, Price LH: Alpha-2 adrenergic receptor sensitivity in depression. Arch Gen Psychiatry 45: 718-726, 1988.
24. Owen JA, Nakatsu SL, Fenemore J: The pharmacokinetics of yohimbine in man. Eur J Clin Pharmacol 32: 577-582, 1987.